Seminar: Non-viral Cell Engineering Advantages and Applications with Stanford University, Touchlight and MaxCyte
This webinar was broadcasted live on November 1, 2023.
In this seminar, cell engineering scientists from Stanford University, Touchlight Genetics, and MaxCyte® shared promising advances in non-viral gene therapy. These experts from across the globe present the latest innovations in gene delivery platforms and single-stranded CRISPR HDR donor technologies.
Continue to webinar
Please fill form below to continue to webinar.